Lujin Wu
Overview
Explore the profile of Lujin Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang Q, Bai Y, Hu S, Ding J, Liu L, Dai M, et al.
Antioxidants (Basel)
. 2023 Nov;
12(11).
PMID: 38001831
Pulmonary vascular remodeling, characterized by the thickening of all three layers of the blood vessel wall, plays a central role in the pathogenesis of pulmonary hypertension (PH). Despite the approval...
2.
Leng Q, Ding J, Dai M, Liu L, Fang Q, Wang D, et al.
Front Cardiovasc Med
. 2022 Jun;
9:879351.
PMID: 35757325
Non-communicable diseases (NCDs), represented by cardiovascular diseases and cancer, have been the leading cause of death globally. Improvements in mortality from cardiovascular (CV) diseases (decrease of 14%/100,000, United States) or...
3.
Shu H, Hang W, Peng Y, Nie J, Wu L, Zhang W, et al.
Front Pharmacol
. 2021 Oct;
12:707399.
PMID: 34603021
Energic deficiency of cardiomyocytes is a dominant cause of heart failure. An antianginal agent, trimetazidine improves the myocardial energetic supply. We presumed that trimetazidine protects the cardiomyocytes from the pressure...
4.
Wu L, Wang W, Leng Q, Tang N, Zhou N, Wang Y, et al.
Front Cardiovasc Med
. 2021 Jul;
8:678645.
PMID: 34307494
The manifestations of hyperthyroidism-related myocardial damage are multitudinous, including arrhythmia, dilated cardiomyopathy, valvular diseases, and even cardiogenic shock. Acute myocarditis induced by thyrotoxicosis had been reported in a few studies....
5.
Ni L, Wen Z, Hu X, Tang W, Wang H, Zhou L, et al.
Front Med
. 2021 Apr;
15(5):704-717.
PMID: 33909260
We conducted a randomized, open-label, parallel-controlled, multicenter trial on the use of Shuanghuanglian (SHL), a traditional Chinese patent medicine, in treating cases of COVID-19. A total of 176 patients received...
6.
Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, et al.
Signal Transduct Target Ther
. 2021 Feb;
6(1):94.
PMID: 33637672
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology, carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified AA on the inner surface of the...
7.
Leng Q, Wang W, Wang Y, Wu L
J Clin Pharm Ther
. 2020 Dec;
46(2):532-538.
PMID: 33277725
What Is Known And Objective: Severe thrombocytopenia associated with systemic lupus erythematosus (SLE) in pregnancy is infrequent. Its occurrence can lead to serious adverse pregnancy consequences and perinatal complications. The...
8.
Wu L, Leng Q, Wang Y, Wang D, Yang D
BMC Pulm Med
. 2020 Nov;
20(1):296.
PMID: 33183266
Background: Mucosal nodules can be caused by infection, inflammation and neoplastic disease. Many noninfectious diseases, such as eosinophilia, amyloidosis, sarcoidosis, Wegener's granuloma, langerhans cell histiocytosis etc., are associated with the...
9.
Wang W, Fang Q, Zhang Z, Wang D, Wu L, Wang Y
Front Pharmacol
. 2020 Nov;
11:528267.
PMID: 33132907
Doxorubicin (DOX), a chemotherapeutic drug widely used in the clinical setting, is known to cause serious cardiotoxicity and greatly reduces the survival rate as well as quality of life of...
10.
Zhao G, Wang X, Edwards S, Dai M, Li J, Wu L, et al.
Eur J Pharmacol
. 2020 Jun;
881:173276.
PMID: 32574674
NLRX1 weakens lipopolysaccharide (LPS)-induced NF-κB activation on immune cells. Cytochrome P450 epoxygenase 2J2 (CYP2J2) attenuates LPS-induced cardiac injury by inhibiting NF-κB activation. However, it is still unclear whether NLRX1 could...